BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 16955485)

  • 1. Functional modulation of parkin through physical interaction with SUMO-1.
    Um JW; Chung KC
    J Neurosci Res; 2006 Nov; 84(7):1543-54. PubMed ID: 16955485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkin ubiquitinates and promotes the degradation of RanBP2.
    Um JW; Min DS; Rhim H; Kim J; Paik SR; Chung KC
    J Biol Chem; 2006 Feb; 281(6):3595-603. PubMed ID: 16332688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex.
    Reverter D; Lima CD
    Nature; 2005 Jun; 435(7042):687-92. PubMed ID: 15931224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neddylation positively regulates the ubiquitin E3 ligase activity of parkin.
    Um JW; Han KA; Im E; Oh Y; Lee K; Chung KC
    J Neurosci Res; 2012 May; 90(5):1030-42. PubMed ID: 22271254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The RanBP2/RanGAP1*SUMO1/Ubc9 complex is a multisubunit SUMO E3 ligase.
    Werner A; Flotho A; Melchior F
    Mol Cell; 2012 May; 46(3):287-98. PubMed ID: 22464730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A ubiquitin ligase HRD1 promotes the degradation of Pael receptor, a substrate of Parkin.
    Omura T; Kaneko M; Okuma Y; Orba Y; Nagashima K; Takahashi R; Fujitani N; Matsumura S; Hata A; Kubota K; Murahashi K; Uehara T; Nomura Y
    J Neurochem; 2006 Dec; 99(6):1456-69. PubMed ID: 17059562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The RanBP2/RanGAP1*SUMO1/Ubc9 SUMO E3 ligase is a disassembly machine for Crm1-dependent nuclear export complexes.
    Ritterhoff T; Das H; Hofhaus G; Schröder RR; Flotho A; Melchior F
    Nat Commun; 2016 May; 7():11482. PubMed ID: 27160050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Covalent ISG15 conjugation positively regulates the ubiquitin E3 ligase activity of parkin.
    Im E; Yoo L; Hyun M; Shin WH; Chung KC
    Open Biol; 2016 Aug; 6(8):. PubMed ID: 27534820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconstitution of the Recombinant RanBP2 SUMO E3 Ligase Complex.
    Ritterhoff T; Das H; Hao Y; Sakin V; Flotho A; Werner A; Melchior F
    Methods Mol Biol; 2016; 1475():41-54. PubMed ID: 27631796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.
    Shimura H; Schlossmacher MG; Hattori N; Frosch MP; Trockenbacher A; Schneider R; Mizuno Y; Kosik KS; Selkoe DJ
    Science; 2001 Jul; 293(5528):263-9. PubMed ID: 11431533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drosophila melanogaster Parkin ubiquitinates peanut and septin1 as an E3 ubiquitin-protein ligase.
    Bae YJ; Kang SJ; Park KS
    Insect Biochem Mol Biol; 2007 May; 37(5):430-9. PubMed ID: 17456438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The autosomal recessive juvenile Parkinson disease gene product, parkin, interacts with and ubiquitinates synaptotagmin XI.
    Huynh DP; Scoles DR; Nguyen D; Pulst SM
    Hum Mol Genet; 2003 Oct; 12(20):2587-97. PubMed ID: 12925569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin.
    Sriram SR; Li X; Ko HS; Chung KK; Wong E; Lim KL; Dawson VL; Dawson TM
    Hum Mol Genet; 2005 Sep; 14(17):2571-86. PubMed ID: 16049031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 14-3-3eta is a novel regulator of parkin ubiquitin ligase.
    Sato S; Chiba T; Sakata E; Kato K; Mizuno Y; Hattori N; Tanaka K
    EMBO J; 2006 Jan; 25(1):211-21. PubMed ID: 16096643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A stable chemical SUMO1-Ubc9 conjugate specifically binds as a thioester mimic to the RanBP2-E3 ligase complex.
    Sommer S; Ritterhoff T; Melchior F; Mootz HD
    Chembiochem; 2015 May; 16(8):1183-9. PubMed ID: 25917782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unique binding interactions among Ubc9, SUMO and RanBP2 reveal a mechanism for SUMO paralog selection.
    Tatham MH; Kim S; Jaffray E; Song J; Chen Y; Hay RT
    Nat Struct Mol Biol; 2005 Jan; 12(1):67-74. PubMed ID: 15608651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkin interacts with LIM Kinase 1 and reduces its cofilin-phosphorylation activity via ubiquitination.
    Lim MK; Kawamura T; Ohsawa Y; Ohtsubo M; Asakawa S; Takayanagi A; Shimizu N
    Exp Cell Res; 2007 Aug; 313(13):2858-74. PubMed ID: 17512523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dyrk1A phosphorylates parkin at Ser-131 and negatively regulates its ubiquitin E3 ligase activity.
    Im E; Chung KC
    J Neurochem; 2015 Aug; 134(4):756-68. PubMed ID: 25963095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sumoylation of the GTPase Ran by the RanBP2 SUMO E3 Ligase Complex.
    Sakin V; Richter SM; Hsiao HH; Urlaub H; Melchior F
    J Biol Chem; 2015 Sep; 290(39):23589-602. PubMed ID: 26251516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The RanBP2/RanGAP1*SUMO1/Ubc9 complex: a multisubunit E3 ligase at the intersection of sumoylation and the RanGTPase cycle.
    Flotho A; Werner A
    Nucleus; 2012; 3(5):429-32. PubMed ID: 22925898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.